Alzheimer’s Disease and Related Dementias project targets a high-impact condition with complex medical and social implications that impact patients, their family members, and their caregivers. Read more

Description

Getting to Measures That Matter

Alzheimer’s Disease, the most common of the dementias, affects an estimated 5.2 million Americans, accounts for 60-80 percent of all dementia cases, and is the sixth leading cause of death in the U.S. overall. Not surprisingly, the economic burden of dementia is high and the emotional and physical burden is immense, not only for the patients suffering themselves, but also for their families and caregivers.

This project seeks to develop a path forward for quality and efficiency measurement to improve care and outcomes for patients with dementia.

Related NQF Work

Prioritizing Measurement: Getting to Measures That Matter

Contact Information

Learn more about this project or the overall Priorities work, you may contact Juliet Feldman at 202-783-1300 or jfeldman@qualityforum.org.

Alzheimer’s Disease and Related Dementias project targets a high-impact condition with complex medical and social implications that impact patients, their family members, and their caregivers. Read more

Sign up for project alert emails that will help you stay informed with our latest project activities. 

Subscribe Now

Prioritizing Measures 

Under contract with HHS, NQF will provide guidance on priorities for performance measure development and endorsement to address the triple aim of the NQS by focusing on five content areas. Learn more about Prioritizing Measures. 

Sign up for project alert emails that will help you stay informed with our latest project activities. 

Subscribe Now

Prioritizing Measures 

Under contract with HHS, NQF will provide guidance on priorities for performance measure development and endorsement to address the triple aim of the NQS by focusing on five content areas. Learn more about Prioritizing Measures. 

Loading...